TEAD4 and malignant colon neoplasm: One such targeted approach may be to direct therapies at disease-specific or sub-optimal splice variants of the Hippo pathway, such as the full length TEAD4 isoform seen in lung and colon cancer [65] and the β, γ, and δ isoforms of YAP with affected TAD domains [69].